Showing results (81-90 of 158) with videos related to
Sort By:
Pageof 16
Development (Cambridge, England)|March 9, 2019
Kidney micro-organoids in suspension culture as a scalable source of human pluripotent stem cell-derived kidney cellsSanthosh V Kumar, Pei X Er, Kynan T Lawlor, et al.Gynecologic Oncology|September 16, 2011
Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centersRoberta Sanfilippo, Federica Grosso, Robin L Jones, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Phase I trials of molecularly targeted agents: should we pay more attention to late toxicities?Sophie Postel-Vinay, Carlos Gomez-Roca, L Rhoda Molife, et al.Nature Communications|October 8, 2022
Enhanced metanephric specification to functional proximal tubule enables toxicity screening and infectious disease modelling in kidney organoidsJessica M Vanslambrouck, Sean B Wilson, Ker Sin Tan, et al.European Journal of Cancer (Oxford, England : 1990)|March 12, 2016
Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entityMyrella Vlenterie, Saskia Litière, Elisa Rizzo, et al.Biorxiv : the Preprint Server for Biology|June 6, 2022
Enhanced metanephric specification to functional proximal tubule enables toxicity screening and infectious disease modelling in kidney organoidsJessica M Vanslambrouck, Sean B Wilson, Ker Sin Tan, et al.Clinical Sarcoma Research|April 30, 2015
First line palliative chemotherapy in elderly patients with advanced soft tissue sarcomaNadia Yousaf, Samuel Harris, Juan Martin-Liberal, et al.Cancers|June 24, 2022
Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous LeiomyomatosisLukas Krasny, Chris P Wilding, Emma Perkins, et al.Investigational New Drugs|August 5, 2010
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanomaSimon Pacey, Martin Gore, David Chao, et al.Anti-Cancer Drugs|January 19, 2017
Pazopanib, a promising option for the treatment of aggressive fibromatosisZoltan Szucs, Christina Messiou, Han Hsi Wong, et al.Pageof 16